Peptide library
A mechanism belongs in mechanism language, an animal model belongs in preclinical language, and a human trial belongs in human-evidence language. Every entry below keeps those apart, and states plainly where the evidence stops.
31 of 31 compounds
5-Amino-1MQ
No human dataA small molecule, not a peptide, that blocks an enzyme called NNMT. The mouse data are consistent and interesting. There are no human trials at all.
- human
- 0
- animal/preclinical
- 4
- reviews
- 1
- sources
- 6
AOD-9604
Early human dataA growth-hormone fragment marketed for fat loss. It was developed as an actual obesity drug, the rigorous trials didn't deliver, it's approved nowhere, and it's banned in sport.
- human
- 3
- animal/preclinical
- 1
- reviews
- 0
- sources
- 5
BPC-157
No human dataBPC-157 is a synthetic pentadecapeptide discussed around tendon, connective-tissue, gut-barrier, vascular-signaling, and preclinical repair models.
- human
- 0
- animal/preclinical
- 3
- reviews
- 1
- sources
- 5
CJC-1295 DAC
Early human dataCJC-1295 DAC is a long-acting GHRH analog research topic with human GH/IGF-1 pharmacology and clear safety limits.
- human
- 2
- animal/preclinical
- 1
- reviews
- 1
- sources
- 5
CJC-1295 no DAC
Early human dataCJC-1295 no DAC is a modified GHRH(1-29) discussion topic centered on GH-axis signaling, pulse-oriented research, and DAC distinction.
- human
- 2
- animal/preclinical
- 1
- reviews
- 0
- sources
- 5
DSIP
Early human dataDSIP was named in 1977 for an effect it was believed to produce. Nearly fifty years later the name is still the strongest evidence for it, and the endogenous peptide tracks the opposite of deep sleep.
- human
- 3
- animal/preclinical
- 1
- reviews
- 1
- sources
- 7
Epitalon
Early human dataEpitalon is a pineal tetrapeptide research topic discussed around telomerase, telomere biology, and longevity claims that require restraint.
- human
- 1
- animal/preclinical
- 1
- reviews
- 1
- sources
- 4
GHK-Cu
No human dataGHK-Cu is a copper-binding tripeptide discussed around skin remodeling, extracellular matrix signaling, collagen context, and reparative biology.
- human
- 0
- animal/preclinical
- 3
- reviews
- 2
- sources
- 6
Glow
No human dataGlow is a blend-style skin and repair discussion entry that requires component-level caution and clear evidence limits.
- human
- 0
- animal/preclinical
- 2
- reviews
- 1
- sources
- 5
Glutathione
Early human dataGlutathione is a redox and antioxidant-system topic discussed around cellular defense, oxidative stress research, and wellness-context evidence.
- human
- 4
- animal/preclinical
- 0
- reviews
- 1
- sources
- 6
IGF-1 LR3
Early human dataAn engineered growth factor sold as a research chemical. No human trials exist. It's banned in all sport at all times, and the FDA-approved version of the same molecule carries a cancer contraindication.
- human
- 2
- animal/preclinical
- 1
- reviews
- 1
- sources
- 7
Ipamorelin
Early human dataIpamorelin is a ghrelin-receptor growth hormone secretagogue discussed around GH-release research, endocrine selectivity, and safety limits.
- human
- 2
- animal/preclinical
- 1
- reviews
- 1
- sources
- 5
Kisspeptin-10
Early human dataKisspeptin-10 is a short signalling peptide that acts upstream of the reproductive hormone axis. The human record is small and acute, and kisspeptin is prohibited in tested sport.
- human
- 2
- animal/preclinical
- 1
- reviews
- 1
- sources
- 5
KPV
No human dataKPV is a C-terminal alpha-MSH tripeptide fragment discussed primarily around gut barrier biology, immune signaling, epithelial context, and preclinical inflammatory-signaling models.
- human
- 0
- animal/preclinical
- 3
- reviews
- 0
- sources
- 4
LL-37
Controlled human trialsLL-37 is the only cathelicidin the human body makes. It has real randomised human trials, all of them topical on chronic ulcers, and the largest one did not beat placebo.
- human
- 3
- animal/preclinical
- 2
- reviews
- 1
- sources
- 8
MK-677
Controlled human trialsAn orally active non-peptide that mimics ghrelin and reliably raises growth hormone and IGF-1. Three randomised placebo-controlled trials measured that rise and could not show it changed strength or physical function.
- human
- 4
- animal/preclinical
- 1
- reviews
- 0
- sources
- 7
MOTS-C
No human dataMOTS-c is a mitochondrial-derived peptide studied for its role in metabolic signaling, stress response, and exercise biology.
- human
- 0
- animal/preclinical
- 2
- reviews
- 3
- sources
- 6
NAD+
Early human dataNAD+ is a cellular redox and energy-metabolism topic tied to mitochondrial biology, aging research, and human precursor studies.
- human
- 4
- animal/preclinical
- 0
- reviews
- 3
- sources
- 9
PEG-MGF
Early human dataPEG-MGF is a pegylated synthetic peptide named after an IGF-1 splice variant. The transcript is real; the peptide has never been isolated from living tissue, and the pegylated form has no published research.
- human
- 1
- animal/preclinical
- 1
- reviews
- 2
- sources
- 7
Pinealon
Early human dataPinealon is a synthetic tripeptide from one Russian research school's peptide family. The laboratory work is real; almost all of it comes from that school, and after thirteen years it is still in cell culture.
- human
- 1
- animal/preclinical
- 3
- reviews
- 1
- sources
- 7
PT-141
Approved medicineAn FDA-approved drug for one narrow condition in one group of women. It is explicitly not approved for men, and not approved to enhance sexual performance. The label says so.
- human
- 3
- animal/preclinical
- 0
- reviews
- 1
- sources
- 6
Retatrutide
Controlled human trialsRetatrutide is an investigational triple GIP, GLP-1 and glucagon agonist with completed Phase 3 obesity data, the strongest human evidence in this library. Not approved; filing expected 2027.
- human
- 3
- animal/preclinical
- 0
- reviews
- 1
- sources
- 5
Selank
Early human dataSelank is a tuftsin-related neuropeptide discussed around GABAergic, stress-response, and regional anxiolytic research context.
- human
- 1
- animal/preclinical
- 2
- reviews
- 1
- sources
- 5
Semax
Early human dataSemax is an ACTH-fragment neuropeptide discussed around BDNF, neurobiology, regional clinical context, and evidence limits.
- human
- 1
- animal/preclinical
- 2
- reviews
- 0
- sources
- 4
Sermorelin
Controlled human trialsSermorelin is a GHRH(1-29) analog that was an approved medicine until 2009, with a real randomised trial record in children and almost none in the adults it is now sold to.
- human
- 12
- animal/preclinical
- 0
- reviews
- 2
- sources
- 18
SLU-PP-332
No human dataSLU-PP-332 is an ERR agonist research compound discussed around exercise-mimetic biology, mitochondrial signaling, and metabolic models.
- human
- 0
- animal/preclinical
- 4
- reviews
- 0
- sources
- 5
SS-31
Approved medicineA mitochondria-targeting peptide studied for its role in cellular energy production. FDA-approved in 2025 for one rare disease, and investigational for everything else.
- human
- 3
- animal/preclinical
- 0
- reviews
- 1
- sources
- 5
TB-500
No human dataTB-500 is a synthetic fragment associated with thymosin beta-4 biology, discussed around actin dynamics, cell migration, vascular signaling, and repair models.
- human
- 0
- animal/preclinical
- 2
- reviews
- 1
- sources
- 5
Tesamorelin
Approved medicineTesamorelin is a GHRH analog with approved medical-use context and endocrine-metabolic relevance that requires precise framing.
- human
- 1
- animal/preclinical
- 0
- reviews
- 3
- sources
- 6
Thymosin Alpha 1
Early human dataA natural immune-system peptide that's used as medicine in many countries, though not approved in the US.
- human
- 1
- animal/preclinical
- 0
- reviews
- 3
- sources
- 5
Thymulin
Early human dataThymulin is a thymic hormone that only works with a zinc ion attached. The human evidence is about zinc status, and every human trial people cite for it belongs to a different thymic preparation.
- human
- 2
- animal/preclinical
- 1
- reviews
- 3
- sources
- 8
